Chunggeun Lee

27PUBLICATIONS
212CO-AUTHORS
ChemotherapyTumour immunologyLiquid biopsiesPredictive and prognostic markersSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 22, 2026
Trastuzumab plus nivolumab with gemcitabine and cisplatin as first-line therapy for HER2-positive unresectable biliary tract cancer: a phase 1b/2 trial.

|Aug 07, 2026
Spatial organisation of tumor-infiltrating B-cells informs immune checkpoint inhibitor response in Claudin 18.2-expressing gastric cancer.

|Apr 06, 2026
Molecular and Phenotypic Characterization of Fluid-Derived Patient-Derived Cell and Organoid Models in Advanced Gastric Cancer.

Ye Jin Moon, Woo Sun Kwon, Chan Hee Park

|Nov 14, 2025
HER2 Positivity as a Prognostic Biomarker and Therapeutic Target in Advanced Biliary Tract Cancer: A Multi-institutional Analysis.

Sunyoung S Lee, Dong Hyun Seo, Taek Chung

|Oct 15, 2025
Long-term Survival Following Endoscopic Submucosal Dissection Versus Gastrectomy in Early Gastric Cancer Patients Aged 75 Years and Above: A National Retrospective Cohort Study in Korea.

Sangwon Lee, Yoon Jin Choi, Bang Wool Eom

|Oct 02, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Cancer Treated With Trastuzumab Plus Folinic Acid, Fluorouracil, and Oxaliplatin.

Hongsik Kim, Chiyoon Oum, Soo Ick Cho

Pageof 5

Frequent Collaborators

10 joint publications

Sun Young Rha

6 joint publications

Woo Sun Kwon

6 joint publications

Minkyu Jung

5 joint publications

Hye Jin Choi